{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:03:46Z","timestamp":1790071426553,"version":"4.0.1"},"publisher-location":"New York, NY","reference-count":59,"publisher":"Springer US","isbn-type":[{"value":"9781071655467","type":"print"},{"value":"9781071655474","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2027]]},"DOI":"10.1007\/978-1-0716-5547-4_4","type":"book-chapter","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:19:14Z","timestamp":1790068754000},"page":"59-74","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Base Editing: Mechanisms and Therapeutic Applications"],"prefix":"10.1007","author":[{"given":"Fabio","family":"Catalano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"issue":"4025","key":"4_CR1","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1126\/science.175.4025.949","volume":"175","author":"T Friedmann","year":"1972","unstructured":"Friedmann T, Roblin R (1972) Gene therapy for human genetic disease?. Science 175(4025):949\u2013955","journal-title":"Science"},{"issue":"4","key":"4_CR2","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1089\/hum.1994.5.4-469","volume":"5","author":"JA Wolff","year":"1994","unstructured":"Wolff JA, Lederberg J (1994) An early history of gene transfer and therapy. Hum Gene Ther 5(4):469\u2013480","journal-title":"Hum Gene Ther"},{"issue":"2","key":"4_CR3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/ng1092-93","volume":"2","author":"T Friedmann","year":"1992","unstructured":"Friedmann T (1992) A brief history of gene therapy. Nat Genet 2(2):93\u201398","journal-title":"Nat Genet"},{"issue":"2","key":"4_CR4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000040930","volume":"101","author":"M Onodera","year":"1999","unstructured":"Onodera M, Nelson DM, Sakiyama Y et al. (1999) Gene therapy for severe combined immunodeficiency caused by adenosine deaminase deficiency: improved retroviral vectors for clinical trials. Acta Haematol 101(2):89\u201396","journal-title":"Acta Haematol"},{"issue":"5235","key":"4_CR5","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1126\/science.270.5235.475","volume":"270","author":"RM Blaese","year":"1995","unstructured":"Blaese RM, Culver KW, Miller AD et al. (1995) T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years. Science 270(5235):475\u2013480","journal-title":"Science"},{"issue":"5","key":"4_CR6","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nrg1066","volume":"4","author":"CE Thomas","year":"2003","unstructured":"Thomas CE, Ehrhardt A, Kay MA (2003) Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 4(5):346\u2013358","journal-title":"Nat Rev Genet"},{"issue":"5","key":"4_CR7","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nbt0505-519","volume":"23","author":"MA Branca","year":"2005","unstructured":"Branca MA (2005) Gene therapy: cursed or inching towards credibility?. Nat Biotechnol 23(5):519\u2013521","journal-title":"Nat Biotechnol"},{"issue":"6753","key":"4_CR8","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/43977","volume":"401","author":"S Lehrman","year":"1999","unstructured":"Lehrman S (1999) Virus treatment questioned after gene therapy death. Nature 401(6753):517\u2013518","journal-title":"Nature"},{"key":"4_CR9","doi-asserted-by":"publisher","first-page":"7603","DOI":"10.1038\/nature17946","volume":"533","author":"AC Komor","year":"2016","unstructured":"Komor AC, Kim YB, Packer MS et al. (2016) Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 533:7603","journal-title":"Nature"},{"issue":"12","key":"4_CR10","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/s41576-018-0059-1","volume":"19","author":"HA Rees","year":"2018","unstructured":"Rees HA, Liu DR (2018) Base editing: precision chemistry on the genome and transcriptome of living cells. Nat Rev Genet 19(12):770\u2013788","journal-title":"Nat Rev Genet"},{"issue":"10","key":"4_CR11","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1056\/NEJMoa2300709","volume":"389","author":"R Chiesa","year":"2023","unstructured":"Chiesa R, Georgiadis C, Syed F et al. (2023) Base-edited CAR7 T cells for relapsed T-cell acute lymphoblastic leukemia. N Engl J Med 389(10):899\u2013910","journal-title":"N Engl J Med"},{"issue":"4","key":"4_CR12","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1093\/cvr\/cvae037","volume":"120","author":"S Tual-Chalot","year":"2024","unstructured":"Tual-Chalot S, Stellos K (2024) First-in-human gene editing for lipid lowering: the initial results. Cardiovasc Res 120(4):e5","journal-title":"Cardiovasc Res"},{"issue":"22","key":"4_CR13","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1056\/NEJMoa2504747","volume":"392","author":"K Musunuru","year":"2025","unstructured":"Musunuru K, Grandinette SA, Wang X et al. (2025) Patient-specific in vivo gene editing to treat a rare genetic disease. N Engl J Med 392(22):2235\u20132243","journal-title":"N Engl J Med"},{"issue":"18","key":"4_CR14","doi-asserted-by":"publisher","first-page":"8522","DOI":"10.1073\/pnas.91.18.8522","volume":"91","author":"PP Lau","year":"1994","unstructured":"Lau PP, Zhu HJ, Baldini A et al. (1994) Dimeric structure of a human apolipoprotein B mRNA editing protein and cloning and chromosomal localization of its gene. Proc Natl Acad Sci USA 91(18):8522\u20138526","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"4_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0005-2760(96)00156-7","volume":"1345","author":"L Chan","year":"1997","unstructured":"Chan L, Chang BHJ, Nakamuta M et al (1997) Apobec-1 and apolipoprotein B mRNA editing. Biochim Biophys Acta 1345(1):11\u201326","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"4_CR16","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aao4774","volume":"3","author":"AC Komor","year":"2017","unstructured":"Komor AC, Zhao KT, Packer MS, et al (2017) Improved base excision repair inhibition and bacteriophage Mu Gam protein yields C:G-to-T:A base editors with higher efficiency and product purity. Sci Adv 3(8), eaao4774.","journal-title":"Sci Adv"},{"issue":"9","key":"4_CR17","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nbt.4172","volume":"36","author":"LW Koblan","year":"2018","unstructured":"Koblan LW, Doman JL, Wilson C et al. (2018) Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction. Nat Biotechnol 36(9):843\u2013848","journal-title":"Nat Biotechnol"},{"issue":"4","key":"4_CR18","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nbt.3803","volume":"35","author":"YB Kim","year":"2017","unstructured":"Kim YB, Komor AC, Levy JM et al. (2017) Increasing the genome-targeting scope and precision of base editing with engineered Cas9-cytidine deaminase fusions. Nat Biotechnol 35(4):371\u2013376","journal-title":"Nat Biotechnol"},{"issue":"1","key":"4_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15887-5","volume":"11","author":"Y Yu","year":"2020","unstructured":"Yu Y, Leete TC, Born DA et al. (2020) Cytosine base editors with minimized unguided DNA and RNA off-target events and high on-target activity. Nat Commun 11(1):2052","journal-title":"Nat Commun"},{"issue":"5","key":"4_CR20","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/s41587-020-0414-6","volume":"38","author":"JL Doman","year":"2020","unstructured":"Doman JL, Raguram A, Newby GA et al. (2020) Evaluation and minimization of Cas9-independent off-target DNA editing by cytosine base editors. Nat Biotechnol 38(5):620\u2013628","journal-title":"Nat Biotechnol"},{"issue":"7681","key":"4_CR21","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nature24644","volume":"551","author":"NM Gaudelli","year":"2017","unstructured":"Gaudelli NM, Komor AC, Rees HA et al. (2017) Programmable base editing of T to G C in genomic DNA without DNA cleavage. Nature 551(7681):464\u2013471","journal-title":"Nature"},{"issue":"5","key":"4_CR22","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41587-022-01533-6","volume":"41","author":"ME Neugebauer","year":"2022","unstructured":"Neugebauer ME, Hsu A, Arbab M et al. (2022) Evolution of an adenine base editor into a small, efficient cytosine base editor with low off-target activity. Nat Biotechnol 41(5):673\u2013685","journal-title":"Nat Biotechnol"},{"issue":"14","key":"4_CR23","doi-asserted-by":"publisher","first-page":"3841","DOI":"10.1093\/emboj\/cdf362","volume":"21","author":"J Wolf","year":"2002","unstructured":"Wolf J, Gerber AP, Keller W (2002) tadA, an essential tRNA-specific adenosine deaminase from Escherichia coli. EMBO J 21(14):3841\u20133851","journal-title":"EMBO J"},{"issue":"7","key":"4_CR24","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/s41587-020-0453-z","volume":"38","author":"MF Richter","year":"2020","unstructured":"Richter MF, Zhao KT, Eton E et al. (2020) Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity. Nat Biotechnol 38(7):883\u2013891","journal-title":"Nat Biotechnol"},{"issue":"7","key":"4_CR25","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1038\/s41587-020-0491-6","volume":"38","author":"NM Gaudelli","year":"2020","unstructured":"Gaudelli NM, Lam DK, Rees HA et al. (2020) Directed evolution of adenine base editors with increased activity and therapeutic application. Nat Biotechnol 38(7):892\u2013900","journal-title":"Nat Biotechnol"},{"issue":"11","key":"4_CR26","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1038\/s41587-021-00943-2","volume":"39","author":"YK Jeong","year":"2021","unstructured":"Jeong YK, Lee SH, Hwang GH et al. (2021) Adenine base editor engineering reduces editing of bystander cytosines. Nat Biotechnol 39(11):1426\u20131433","journal-title":"Nat Biotechnol"},{"issue":"7756","key":"4_CR27","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s41586-019-1161-z","volume":"569","author":"J Gr\u00fcnewald","year":"2019","unstructured":"Gr\u00fcnewald J, Zhou R, Garcia SP et al. (2019) Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors. Nature 569(7756):433\u2013437","journal-title":"Nature"},{"issue":"1","key":"4_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22519-z","volume":"12","author":"J Li","year":"2021","unstructured":"Li J, Yu W, Huang S et al. (2021) Structure-guided engineering of adenine base editor with minimized RNA off-targeting activity. Nat Commun 12(1):2287","journal-title":"Nat Commun"},{"issue":"5","key":"4_CR29","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aax5717","volume":"5","author":"HA Rees","year":"2019","unstructured":"Rees HA, Wilson C, Doman JL, et al. (2019) Analysis and minimization of cellular RNA editing by DNA adenine base editors. Sci Adv 5(5), eaax5717.","journal-title":"Sci Adv"},{"issue":"1","key":"4_CR30","doi-asserted-by":"publisher","first-page":"4804","DOI":"10.1038\/s41467-018-07322-7","volume":"9","author":"HK Lee","year":"2018","unstructured":"Lee HK, Willi M, Miller SM, et al. (2018) Targeting fidelity of adenine and cytosine base editors in mouse embryos. Nat Commun 9(1):4804.","journal-title":"Nat Commun"},{"issue":"1","key":"4_CR31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s42003-019-0745-3","volume":"3","author":"HK Lee","year":"2020","unstructured":"Lee HK, Smith HE, Liu C et al. (2020) Cytosine base editor 4 but not adenine base editor generates off-target mutations in mouse embryos. Commun Biol 3(1):19","journal-title":"Commun Biol"},{"issue":"6","key":"4_CR32","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/s41587-023-01915-4","volume":"42","author":"M Fiumara","year":"2023","unstructured":"Fiumara M, Ferrari S, Omer-Javed A et al. (2023) Genotoxic effects of base and prime editing in human hematopoietic stem cells. Nat Biotechnol 42(6):877\u2013891","journal-title":"Nat Biotechnol"},{"issue":"1","key":"4_CR33","doi-asserted-by":"publisher","first-page":"6353","DOI":"10.1038\/s41467-021-26461-y","volume":"12","author":"A T\u00e1las","year":"2021","unstructured":"T\u00e1las A, Simon DA, Kulcs\u00e1r PI, et al. (2021) BEAR reveals that increased fidelity variants can successfully reduce the mismatch tolerance of adenine but not cytosine base editors. Nat Commun 12(1):6353.","journal-title":"Nat Commun"},{"issue":"1","key":"4_CR34","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41587-020-0592-2","volume":"39","author":"D Zhao","year":"2020","unstructured":"Zhao D, Li J, Li S et al. (2020) Glycosylase base editors enable C-to-A and C-to-G base changes. Nat Biotechnol 39(1):35\u201340","journal-title":"Nat Biotechnol"},{"issue":"1","key":"4_CR35","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41587-020-0609-x","volume":"39","author":"IC Kurt","year":"2021","unstructured":"Kurt IC, Zhou R, Iyer S et al. (2021) CRISPR C-to-G base editors for inducing targeted DNA transversions in human cells. Nat Biotechnol 39(1):41\u201346","journal-title":"Nat Biotechnol"},{"issue":"11","key":"4_CR36","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1038\/s41587-021-00938-z","volume":"39","author":"LW Koblan","year":"2021","unstructured":"Koblan LW, Arbab M, Shen MW et al. (2021) Efficient C G-to-G C base editors developed using CRISPRi screens, target-library analysis, and machine learning. Nat Biotechnol 39(11):1414\u20131425","journal-title":"Nat Biotechnol"},{"issue":"8","key":"4_CR37","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/s41587-022-01595-6","volume":"41","author":"H Tong","year":"2023","unstructured":"Tong H, Wang X, Liu Y et al. (2023) Programmable A-to-Y base editing by fusing an adenine base editor with an N-methylpurine DNA glycosylase. Nat Biotechnol 41(8):1080\u20131084","journal-title":"Nat Biotechnol"},{"issue":"4","key":"4_CR38","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/s41587-023-01821-9","volume":"42","author":"L Chen","year":"2024","unstructured":"Chen L, Hong M, Luan C et al. (2024) Adenine transversion editors enable precise, efficient A\u2022T-to-C\u2022G base editing in mammalian cells and embryos. Nat Biotechnol 42(4):638\u2013650","journal-title":"Nat Biotechnol"},{"issue":"8","key":"4_CR39","doi-asserted-by":"publisher","DOI":"10.1093\/nsr\/nwad143","volume":"10","author":"H Tong","year":"2023","unstructured":"Tong H, Liu N, Wei Y, et al. (2023) Programmable deaminase-free base editors for G-to-Y conversion by engineered glycosylase. Natl Sci Rev 10(8), nwad143.","journal-title":"Natl Sci Rev"},{"issue":"1","key":"4_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49343-5","volume":"15","author":"H Tong","year":"2024","unstructured":"Tong H, Wang H, Wang X et al. (2024) Development of deaminase-free T-to-S base editor and C-to-G base editor by engineered human uracil DNA glycosylase. Nat Commun 15(1):4897","journal-title":"Nat Commun"},{"issue":"9","key":"4_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107723","volume":"31","author":"X Wang","year":"2020","unstructured":"Wang X, Ding C, Yu W, et al. (2020) Cas12a base editors induce efficient and specific editing with low DNA damage response. Cell Rep 31(9), 107723.","journal-title":"Cell Rep"},{"issue":"1","key":"4_CR42","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1038\/s42003-022-04152-8","volume":"5","author":"F Chen","year":"2022","unstructured":"Chen F, Lian M, Ma B, et al. (2022) Multiplexed base editing through Cas12a variant-mediated cytosine and adenine base editors. Commun Biol 5(1):1163.","journal-title":"Commun Biol"},{"issue":"1","key":"4_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36004-2","volume":"14","author":"S Zhang","year":"2023","unstructured":"Zhang S, Song L, Yuan B et al. (2023) TadA reprogramming to generate potent miniature base editors with high precision. Nat Commun 14(1):413","journal-title":"Nat Commun"},{"issue":"11","key":"4_CR44","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1038\/s41589-023-01380-9","volume":"19","author":"T Wu","year":"2023","unstructured":"Wu T, Liu C, Zou S et al. (2023) An engineered hypercompact CRISPR-Cas12f system with boosted gene-editing activity. Nat Chem Biol 19(11):1384\u20131393","journal-title":"Nat Chem Biol"},{"issue":"7817","key":"4_CR45","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/s41586-020-2477-4","volume":"583","author":"BY Mok","year":"2020","unstructured":"Mok BY, de Moraes MH, Zeng J et al. (2020) A bacterial cytidine deaminase toxin enables CRISPR-free mitochondrial base editing. Nature 583(7817):631","journal-title":"Nature"},{"issue":"8","key":"4_CR46","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/s41594-023-01034-3","volume":"30","author":"L Yin","year":"2023","unstructured":"Yin L, Shi K, Aihara H (2023) Structural basis of sequence-specific cytosine deamination by double-stranded DNA deaminase toxin DddA. Nat Struct Mol Biol 30(8):1153\u20131159","journal-title":"Nat Struct Mol Biol"},{"issue":"9","key":"4_CR47","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1038\/s41587-022-01256-8","volume":"40","author":"BY Mok","year":"2022","unstructured":"Mok BY, Kotrys AV, Raguram A et al. (2022) CRISPR-free base editors with enhanced activity and expanded targeting scope in mitochondrial and nuclear DNA. Nat Biotechnol 40(9):1378\u20131387","journal-title":"Nat Biotechnol"},{"issue":"3","key":"4_CR48","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41587-022-01486-w","volume":"41","author":"S Lee","year":"2022","unstructured":"Lee S, Lee H, Baek G et al. (2022) Precision mitochondrial DNA editing with high-fidelity DddA-derived base editors. Nat Biotechnol 41(3):378\u2013386","journal-title":"Nat Biotechnol"},{"issue":"10","key":"4_CR49","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1016\/j.cell.2022.03.039","volume":"185","author":"SI Cho","year":"2022","unstructured":"Cho SI, Lee S, Mok YG et al. (2022) Targeted A-to-G base editing in human mitochondrial DNA with programmable deaminases. Cell 185(10):1764\u20131776","journal-title":"Cell"},{"issue":"1","key":"4_CR50","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.cell.2023.11.035","volume":"187","author":"SI Cho","year":"2024","unstructured":"Cho SI, Lim K, Hong S et al. (2024) Engineering TALE-linked deaminases to facilitate precision adenine base editing in mitochondrial DNA. Cell 187(1):95\u2013109","journal-title":"Cell"},{"issue":"11","key":"4_CR51","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1038\/s41551-022-00911-4","volume":"6","author":"JR Davis","year":"2022","unstructured":"Davis JR, Wang X, Witte IP et al. (2022) Efficient in vivo base editing via single adeno-associated viruses with size-optimized genomes encoding compact adenine base editors. Nat Biomed Eng 6(11):1272\u20131283","journal-title":"Nat Biomed Eng"},{"issue":"6","key":"4_CR52","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/s41565-021-00898-0","volume":"16","author":"JA Kulkarni","year":"2021","unstructured":"Kulkarni JA, Witzigmann D, Thomson SB et al. (2021) The current landscape of nucleic acid therapeutics. Nature Nanotechnology 16(6):630\u2013643","journal-title":"Nature Nanotechnology"},{"issue":"4","key":"4_CR53","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","volume":"15","author":"Q Cheng","year":"2020","unstructured":"Cheng Q, Wei T, Farbiak L et al. (2020) Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing. Nat Nanotechnol 15(4):313\u2013320","journal-title":"Nat Nanotechnol"},{"issue":"4","key":"4_CR54","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41587-025-02675-z","volume":"44","author":"M Kim","year":"2025","unstructured":"Kim M, Song ES, Chen JC, et al. (2025) Dual SORT LNPs for multi-organ base editing. Nat Biotechnol 44(4):578\u2013586.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"4_CR55","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41563-025-02331-6","volume":"25","author":"T Chang","year":"2026","unstructured":"Chang T, Zheng Y, Jiang M et al. (2026) Peptide codes for organ-selective mRNA delivery. Nat Mater 25(1):146\u2013159","journal-title":"Nat Mater"},{"issue":"10","key":"4_CR56","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1038\/s41587-024-02467-x","volume":"43","author":"A Raguram","year":"2025","unstructured":"Raguram A, An M, Chen PZ et al. (2025) Directed evolution of engineered virus-like particles with improved production and transduction efficiencies. Nat Biotechnol 43(10):1635\u20131647","journal-title":"Nat Biotechnol"},{"issue":"1","key":"4_CR57","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12987-022-00359-3","volume":"19","author":"HM Ramos-Zald\u00edvar","year":"2022","unstructured":"Ramos-Zald\u00edvar HM, Polakovicova I, Salas-Huenuleo E et al. (2022) Extracellular vesicles through the blood\u2013brain barrier: a review. Fluids Barriers CNS 19(1):60","journal-title":"Fluids Barriers CNS"},{"issue":"18","key":"4_CR58","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1056\/NEJMoa2504835","volume":"394","author":"AO Gupta","year":"2026","unstructured":"Gupta AO, Sharma A, Frangoul H, et al. (2026) Base editing of HBG1 and HBG2 promoters for sickle cell disease. N Engl J Med 394(18):1824\u20131835.","journal-title":"N Engl J Med"},{"key":"4_CR59","first-page":"1","volume":"8","author":"Y Lai","year":"2026","unstructured":"Lai Y, Liu R, Wang L et al. (2026) Clinical application of base editing for treating \u03b2-thalassaemia. Nature 8:1\u201310","journal-title":"Nature"}],"container-title":["Methods in Molecular Biology","CRISPR Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5547-4_4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:19:15Z","timestamp":1790068755000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5547-4_4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"ISBN":["9781071655467","9781071655474"],"references-count":59,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5547-4_4","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]},"assertion":[{"value":"23 September 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"The author declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}